Therapeutic targeting |
Inhibit signaling pathway |
IL6 binder |
Inhibits IL-6 induced signaling pathway in non-small cell lung cancer cells |
[29] |
|
Inhibit signaling pathway |
C5a binder |
Inhibits C5a pathway to suppress proinflammatory response |
[27] |
|
Inhibit signaling pathway |
VEGF binder |
Blocks the VEGF signaling pathway for age-related macular degeneration |
[33] |
Drug delivery |
CAR-VLR |
B-cells and CD5 binder |
Expresses on effector cells, redirect to target cells, and activates cytotoxicity |
[34] |
|
VLR-drug conjugate |
EGFR binder |
Chemoenzymatically attaches drug for tumor suppression |
[35] |
|
Nanoparticle |
EGFR binder |
Self-assembled nanoparticles target tumors |
[36] |
Diagnostics/Imaging |
Biomarker discovery |
CD38 binder |
Novel epitope that exclusively binds PCs |
[30] |
|
Diagnostics |
TF-α binder |
Stains tumor tissue with worse survival rate |
[20] |
|
Diagnostics |
Anti-idiotype binder |
Used to monitor lymphocytic leukemia |
[37] |
|
Molecular imaging |
EGFR binder |
In vivo tumor imaging |
[38,39] |
|
Molecular imaging |
mCherry binder |
Tracks protein-protein interaction in real time |
[40] |
|
Plant research |
HopM1 binder |
Expresses and binds in some plant environments |
[28] |
Other |
Stabilization |
Consensus sequence |
Able to crystalize LRRTM2 by altering convex surface based on VLR sequence |
[41] |
|
Stabilization |
Stable caps |
Resolves crystal structure of LRR proteins using caps comprised of VLR sequence |
[42,43] |
|
Vaccine carrier |
Multimerizing tail |
Creates multimer with hidden VLR sequence resulting in high vaccine Ab titers |
[44] |